???pagination.result.count???
???pagination.result.page???
1
CaM kinase IV regulates lineage commitment and survival of erythroid progenitors in a non-cell-autonomous manner. , Wayman GA., J Cell Biol. November 13, 2000; 151 (4): 811-24.
The bHLH factors Xath5 and XNeuroD can upregulate the expression of XBrn3d, a POU-homeodomain transcription factor. , Hutcheson DA ., Dev Biol. April 15, 2001; 232 (2): 327-38.
Role of the thrombopoietin ( TPO)/Mpl system: c-Mpl-like molecule/ TPO signaling enhances early hematopoiesis in Xenopus laevis. , Kakeda M., Dev Growth Differ. February 1, 2002; 44 (1): 63-75.
The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia. , Rawat VP., Proc Natl Acad Sci U S A. September 28, 2010; 107 (39): 16946-51.
EBF factors drive expression of multiple classes of target genes governing neuronal development. , Green YS., Neural Dev. April 30, 2011; 6 19.
Xaml1/ Runx1 is required for the specification of Rohon-Beard sensory neurons in Xenopus. , Park BY., Dev Biol. February 1, 2012; 362 (1): 65-75.
The Xenopus doublesex-related gene Dmrt5 is required for olfactory placode neurogenesis. , Parlier D., Dev Biol. January 1, 2013; 373 (1): 39-52.
Hippo signaling components, Mst1 and Mst2, act as a switch between self-renewal and differentiation in Xenopus hematopoietic and endothelial progenitors. , Nejigane S., Int J Dev Biol. January 1, 2013; 57 (5): 407-14.
Regulation of primitive hematopoiesis by class I histone deacetylases. , Shah RR., Dev Dyn. February 1, 2013; 242 (2): 108-21.
MRAS GTPase is a novel stemness marker that impacts mouse embryonic stem cell plasticity and Xenopus embryonic cell fate. , Mathieu ME., Development. August 1, 2013; 140 (16): 3311-22.
Regulation of neurogenesis by Fgf8a requires Cdc42 signaling and a novel Cdc42 effector protein. , Hulstrand AM., Dev Biol. October 15, 2013; 382 (2): 385-99.
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy. , Raymond A., Oncotarget. December 30, 2014; 5 (24): 12675-93.